Compass Therapeutics (CMPX)

SG&A Expense Growth

12.92%

Quarterly · Period ending:

CMPX logo

CMPX SG&A Expense Growth

Latest reported12.92%
CMPX Quarterly SG&A Growth (QoQ) (0.00% → 12.92%)
High-resolution chart · PNG

CMPX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Compass Therapeutics SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
12.9195%
51.8999%
44.2996%
-35.6912%
-5.3135%
38.914%
-2.509%
-23.1731%
45.351%
9.4708%
-4.1357%
-0.6101%
1.3342%
3.8176%
5.4507%
-10.176%
12.9382%
-19.2588%
26.9259%
24.6537%
-17.7989%
-25.649%
-33.0183%
153.765%
-7.7434%
-27.0732%
28.9101%
-26.7966%
-1.9994%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.